Literature DB >> 6341859

Common site of integration of HTLV in cells of three patients with mature T-cell leukaemia-lymphoma.

B Hahn, V Manzari, S Colombini, G Franchini, R C Gallo, F Wong-Staal.   

Abstract

Human T-cell leukaemia-lymphoma virus (HTLV) was first isolated in the United States from a patient with an aggressive form of cutaneous T-cell lymphoma (CTCL) and was later found associated with clusters of adult T-cell leukaemia-lymphomas (ATL) in various parts of the world, including Japan and the Caribbean. Leukaemic cells of the HTLV-positive patients seem to be clonal expansions of single infected cells since the provirus(es) are found at the same sites in a given patient. In avian leukosis virus-induced B-cell lymphomas, the provirus very frequently integrates at several discrete sites in a common domain near the cellular gene, c-myc, that it activates and it has been speculated that the same would hold true for other chronic leukaemia viruses. We report here that cultured cells from two US patients with CTCL and fresh leukaemia cells of a Japanese patient with ATL contained an HTLV provirus integrated at the same site. In addition, a cord blood T-lymphocyte cell line established by co-cultivation with one of the two HTLV-positive CTCL cell lines also contained HTLV provirus contiguous with the same flanking cellular sequences. Ten other HTLV-positive cell samples did not show integration of HTLV at this site, suggesting that there is more than one discrete site of HTLV integration in tumour cells.

Entities:  

Mesh:

Year:  1983        PMID: 6341859     DOI: 10.1038/303253a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  Detection of covalent triplex within human cells.

Authors:  A L Guieysse; D Praseuth; M Grigoriev; A Harel-Bellan; C Hélène
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

2.  A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat.

Authors:  S J Marriott; P F Lindholm; K M Brown; S D Gitlin; J F Duvall; M F Radonovich; J N Brady
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.

Authors:  Mark Page; Ruby Quartey-Papafio; Mark Robinson; Mark Hassall; Martin Cranage; James Stott; Neil Almond
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.